Biostar Pharma Appoints New CFO
Mr Chen has replaced Elaine Zhao, who resigned effective at the close of business on June 30, 2010. Most recently, Mr Chen was an independent advisor engaged in
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.